发布求助
文献互助 智能选刊 最新文献

Emerging Infectious Diseases最新文献

筛选
英文 中文
Epidemiology of Streptococcus pyogenes Disease before, during, and after COVID-19 Pandemic, Germany, 2005–2023 2005-2023 年 COVID-19 大流行之前、期间和之后德国化脓性链球菌疾病的流行病学情况
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-17 DOI: 10.3201/eid3011.231667
Irene Burckhardt, Florian Burckhardt
{"title":"Epidemiology of Streptococcus pyogenes Disease before, during, and after COVID-19 Pandemic, Germany, 2005–2023","authors":"Irene Burckhardt, Florian Burckhardt","doi":"10.3201/eid3011.231667","DOIUrl":"https://doi.org/10.3201/eid3011.231667","url":null,"abstract":"<p>We analyzed 3,081 invasive and noninvasive <em>Streptococcus pyogenes</em> cases (January 2005–December 2023) at a tertiary care hospital in southwest Germany. Absolute numbers of case-patients increased each year from 2005 until the COVID-19 pandemic. Odds ratios for invasive streptococcal disease were significantly influenced by year, male sex, and older age.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142448672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Quantitative SARS-CoV-2 Spike Receptor-Binding Domain and Neutralizing Antibody Titers in Previously Infected Persons, United States, January 2021–February 2022 2021 年 1 月至 2022 年 2 月美国既往感染者的 SARS-CoV-2 穗状受体结合域和中和抗体滴度定量数据
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-17 DOI: 10.3201/eid3011.240043
Anna Bratcher, Szu-Yu Kao, Kelly Chun, Christos J. Petropoulos, Adi V. Gundlapalli, Jefferson Jones, Kristie E.N. Clarke
{"title":"Quantitative SARS-CoV-2 Spike Receptor-Binding Domain and Neutralizing Antibody Titers in Previously Infected Persons, United States, January 2021–February 2022","authors":"Anna Bratcher, Szu-Yu Kao, Kelly Chun, Christos J. Petropoulos, Adi V. Gundlapalli, Jefferson Jones, Kristie E.N. Clarke","doi":"10.3201/eid3011.240043","DOIUrl":"https://doi.org/10.3201/eid3011.240043","url":null,"abstract":"<p>We studied SARS-CoV-2 binding and neutralizing antibody titers among previously infected persons in the United States over time. We assayed SARS-CoV-2 spike protein receptor-binding domain and neutralizing antibody titers for a convenience sample of residual clinical serum specimens that had evidence of prior SARS-CoV-2 infection gathered during January 2021–February 2022. We correlated titers and examined them by age group (&lt;18, 18–49, 50–64, and <span>&gt;</span>65 years) across 4 different SARS-CoV-2 variant epochs. Among selected specimens, 30,967 had binding antibody titers and 744 had neutralizing titers available. Titers in specimens from children and adults correlated. In addition, mean binding antibody titers increased over time for all age groups, and mean neutralization titers increased over time for persons 16–49 and <span>&gt;</span>65 years of age. Incorporating binding and neutralization antibody titers into infectious disease surveillance could provide a clearer picture of overall immunity and help target vaccination campaigns.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-17","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142448605","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Vibrio parahaemolyticus Foodborne Illness Associated with Oysters, Australia, 2021–2022 澳大利亚与牡蛎有关的副溶血性弧菌食源性疾病，2021-2022 年
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-16 DOI: 10.3201/eid3011.240172
Emily Fearnley, Lex E.X. Leong, Alessia Centofanti, Paul Dowsett, Barry G. Combs, Anthony D.K. Draper, Helen Hocking, Ben Howden, Kristy Horan, Mathilda Wilmot, Avram Levy, Louise A. Cooley, Karina J. Kennedy, Qinning Wang, Alicia Arnott, Rikki M.A. Graham, Vitali Sinchenko, Amy V. Jennison, Stacey Kane, Rose Wright
{"title":"Vibrio parahaemolyticus Foodborne Illness Associated with Oysters, Australia, 2021–2022","authors":"Emily Fearnley, Lex E.X. Leong, Alessia Centofanti, Paul Dowsett, Barry G. Combs, Anthony D.K. Draper, Helen Hocking, Ben Howden, Kristy Horan, Mathilda Wilmot, Avram Levy, Louise A. Cooley, Karina J. Kennedy, Qinning Wang, Alicia Arnott, Rikki M.A. Graham, Vitali Sinchenko, Amy V. Jennison, Stacey Kane, Rose Wright","doi":"10.3201/eid3011.240172","DOIUrl":"https://doi.org/10.3201/eid3011.240172","url":null,"abstract":"<p>The bacterium <em>Vibrio parahaemolyticus</em> is ubiquitous in tropical and temperate waters throughout the world and causes infections in humans resulting from water exposure and from ingestion of contaminated raw or undercooked seafood, such as oysters. We describe a nationwide outbreak of enteric infections caused by <em>Vibrio parahaemolyticus</em> in Australia during September 2021–January 2022. A total of 268 persons were linked with the outbreak, 97% of whom reported consuming Australia-grown oysters. Cases were reported from all states and territories of Australia. The outbreak comprised 2 distinct strains of <em>V. parahaemolyticus,</em> sequence types 417 and 50. We traced oysters with <em>V. parahaemolyticus</em> proliferation back to a common growing region within the state of South Australia. The outbreak prompted a national recall of oysters and subsequent improvements in postharvest processing of the shellfish.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142443919","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Conceptual Framework for Community-Based Prevention of Brown Dog Tick–Associated Rocky Mountain Spotted Fever 以社区为基础预防褐狗蜱相关落基山斑疹热的概念框架
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-16 DOI: 10.3201/eid3011.240293
Maureen K. Brophy, Erica Weis, Naomi A. Drexler, Christopher D. Paddock, William L. Nicholson, Gilbert J. Kersh, Johanna S. Salzer
{"title":"Conceptual Framework for Community-Based Prevention of Brown Dog Tick–Associated Rocky Mountain Spotted Fever","authors":"Maureen K. Brophy, Erica Weis, Naomi A. Drexler, Christopher D. Paddock, William L. Nicholson, Gilbert J. Kersh, Johanna S. Salzer","doi":"10.3201/eid3011.240293","DOIUrl":"https://doi.org/10.3201/eid3011.240293","url":null,"abstract":"<p>Rocky Mountain spotted fever (RMSF) is a severe tickborne disease that can reach epidemic proportions in communities with certain social and ecologic risk factors. In some areas, the case-fatality rate of brown dog tick-associated RMSF is up to 50%. Because of the spread of brown dog tick–associated RMSF in the southwestern United States and northern Mexico, the disease has the potential to emerge and become endemic in other communities that have large populations of free-roaming dogs, brown dog ticks, limited resources, and low provider awareness of the disease. By using a One Health approach, interdisciplinary teams can identify communities at risk and prevent severe or fatal RMSF in humans before cases occur. We have developed a conceptual framework for RMSF prevention to enable communities to identify their RMSF risk level and implement prevention and control strategies.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142443920","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flexible Development Programs for Antibacterial Drugs to Address Unmet Medical Needs 灵活的抗菌药物开发计划，满足未满足的医疗需求
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-09 DOI: 10.3201/eid3011.231416
Mayurika Ghosh, Dmitri Iarikov, Xiaojing (Karen) Qi, Daniel Rubin, Simone Shurland, Avery Goodwin, Xiaohui Wei, Dakshina Chilukuri, Owen McMaster, Terry Miller, Peter Kim, Adam Sherwat
{"title":"Flexible Development Programs for Antibacterial Drugs to Address Unmet Medical Needs","authors":"Mayurika Ghosh, Dmitri Iarikov, Xiaojing (Karen) Qi, Daniel Rubin, Simone Shurland, Avery Goodwin, Xiaohui Wei, Dakshina Chilukuri, Owen McMaster, Terry Miller, Peter Kim, Adam Sherwat","doi":"10.3201/eid3011.231416","DOIUrl":"https://doi.org/10.3201/eid3011.231416","url":null,"abstract":"<p>The US Food and Drug Administration recognizes the unmet medical need for antibacterial drugs to treat serious bacterial diseases caused by resistant pathogens for which effective therapies are limited or lacking. The agency also recognizes that designing and conducting clinical trials to assess the safety and efficacy of drugs to treat resistant infections is challenging, especially for drugs only active against a single or a few bacterial species, and that a more flexible development program might be appropriate. In this article, we discuss several regulatory considerations for flexible development programs for antibacterial drugs intended to meet an unmet medical need. As an example, we use the recent approval of sulbactam for injection and durlobactam for injection (XACDURO) for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia caused by susceptible isolates of <em>Acinetobacter baumannii-calcoaceticus</em> complex.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142405286","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evidence of Human Bourbon Virus Infections, North Carolina, USA 人类波旁病毒感染证据，美国北卡罗来纳州
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-09 DOI: 10.3201/eid3011.240499
Diana L. Zychowski, Gayan Bamunuarachchi, Scott P. Commins, Ross M. Boyce, Adrianus C.M. Boon
{"title":"Evidence of Human Bourbon Virus Infections, North Carolina, USA","authors":"Diana L. Zychowski, Gayan Bamunuarachchi, Scott P. Commins, Ross M. Boyce, Adrianus C.M. Boon","doi":"10.3201/eid3011.240499","DOIUrl":"https://doi.org/10.3201/eid3011.240499","url":null,"abstract":"<p>Bourbon virus is a tickborne virus that can cause human disease. Cases have been reported in Kansas, Oklahoma, and Missouri, USA. We identified Bourbon virus–specific neutralizing antibodies in patients from North Carolina. Bourbon virus infections are likely more common than previously thought, highlighting the need for improved diagnostics and surveillance.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142405199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Rocky Mountain Spotted Fever in Children along the US‒Mexico Border, 2017–2023 2017-2023 年美墨边境儿童落基山斑疹热病例
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-09 DOI: 10.3201/eid3011.231760
Leslie Chiang, Nanda Ramchandar, Jacquelyn Aramkul, Yaron Fireizen, Mark E. Beatty, Madeleine Monroe, Seema Shah, Jennifer Foley, Nicole G. Coufal
{"title":"Rocky Mountain Spotted Fever in Children along the US‒Mexico Border, 2017–2023","authors":"Leslie Chiang, Nanda Ramchandar, Jacquelyn Aramkul, Yaron Fireizen, Mark E. Beatty, Madeleine Monroe, Seema Shah, Jennifer Foley, Nicole G. Coufal","doi":"10.3201/eid3011.231760","DOIUrl":"https://doi.org/10.3201/eid3011.231760","url":null,"abstract":"<p>Rocky mountain spotted fever (RMSF) causes significant illness and death in children. Although historically rare in California, USA, RMSF is endemic in areas of northern Mexico that border California. We describe 7 children with RMSF who were hospitalized at a tertiary pediatric referral center in California during 2017–2023. Five children had recent travel to Mexico with presumptive exposure, but 2 children did not report any travel outside of California. In all 7 patients, <em>Rickettsia rickettsii</em> DNA was detected by plasma microbial cell-free next-generation sequencing, which may be a useful diagnostic modality for RMSF, especially early in the course of illness, when standard diagnostic tests for RMSF are of limited sensitivity. A high index of suspicion and awareness of local epidemiologic trends remain most critical to recognizing the clinical syndrome of RMSF and initiating appropriate antimicrobial therapy in a timely fashion.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142405281","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dengue Outbreak Caused by Multiple Virus Serotypes and Lineages, Colombia, 2023–2024 2023-2024 年哥伦比亚由多种病毒血清型和系谱引起的登革热疫情
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-08 DOI: 10.3201/eid3011.241031
Nathan D. Grubaugh, Daniela Torres-Hernández, Mónica A. Murillo-Ortiz, Diana M. Dávalos, Pio Lopez, Isabel C. Hurtado, Mallery I. Breban, Ellie Bourgikos, Verity Hill, Eduardo López-Medina
{"title":"Dengue Outbreak Caused by Multiple Virus Serotypes and Lineages, Colombia, 2023–2024","authors":"Nathan D. Grubaugh, Daniela Torres-Hernández, Mónica A. Murillo-Ortiz, Diana M. Dávalos, Pio Lopez, Isabel C. Hurtado, Mallery I. Breban, Ellie Bourgikos, Verity Hill, Eduardo López-Medina","doi":"10.3201/eid3011.241031","DOIUrl":"https://doi.org/10.3201/eid3011.241031","url":null,"abstract":"<p>Dengue cases rose to record levels during 2023–2024. We investigated dengue in Valle del Cauca, Colombia, to determine if specific virus serotypes or lineages caused its large outbreak. We detected all 4 serotypes and multiple lineages, suggesting that factors such as climatic conditions were likely responsible for increased dengue in Colombia.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142385167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States 美国从人类身上分离出的猪源性甲型流感病毒的抗病毒敏感性
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-08 DOI: 10.3201/eid3011.240892
Rongyuan Gao, Philippe Noriel Q. Pascua, Anton Chesnokov, Ha T. Nguyen, Timothy M. Uyeki, Vasiliy P. Mishin, Natosha Zanders, Dan Cui, Yunho Jang, Joyce Jones, Juan De La Cruz, Han Di, Charles Todd Davis, Larisa V. Gubareva
{"title":"Antiviral Susceptibility of Swine-Origin Influenza A Viruses Isolated from Humans, United States","authors":"Rongyuan Gao, Philippe Noriel Q. Pascua, Anton Chesnokov, Ha T. Nguyen, Timothy M. Uyeki, Vasiliy P. Mishin, Natosha Zanders, Dan Cui, Yunho Jang, Joyce Jones, Juan De La Cruz, Han Di, Charles Todd Davis, Larisa V. Gubareva","doi":"10.3201/eid3011.240892","DOIUrl":"https://doi.org/10.3201/eid3011.240892","url":null,"abstract":"<p>Since 2013, a total of 167 human infections with swine-origin (variant) influenza A viruses of A(H1N1)v, A(H1N2)v, and A(H3N2)v subtypes have been reported in the United States. Analysis of 147 genome sequences revealed that nearly all had S31N substitution, an M2 channel blocker-resistance marker, whereas neuraminidase inhibitor–resistance markers were not found. Two viruses had a polymerase acidic substitution (I38M or E199G) associated with decreased susceptibility to baloxavir, an inhibitor of viral cap-dependent endonuclease (CEN). Using phenotypic assays, we established subtype-specific susceptibility baselines for neuraminidase and CEN inhibitors. When compared with either baseline or CEN-sequence–matched controls, only the I38M substitution decreased baloxavir susceptibility, by 27-fold. Human monoclonal antibodies FI6v3 and CR9114 targeting the hemagglutinin’s stem showed variable (0.03 to &gt;10 µg/mL) neutralizing activity toward variant viruses, even within the same clade. Methodology and interpretation of laboratory data described in this study provide information for risk assessment and decision-making on therapeutic control measures.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142385168","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Replication-Competent Oropouche Virus in Semen of Traveler Returning to Italy from Cuba, 2024 2024 年从古巴返回意大利的旅行者精液中复制能力强的奥罗普切病毒
IF 11.8 2区 医学
Emerging Infectious Diseases Pub Date : 2024-10-07 DOI: 10.3201/eid3012.241470
Concetta Castilletti, Ralph Huits, Rebeca Passarelli Mantovani, Silvia Accordini, Francesca Alladio, Federico Gobbi
{"title":"Replication-Competent Oropouche Virus in Semen of Traveler Returning to Italy from Cuba, 2024","authors":"Concetta Castilletti, Ralph Huits, Rebeca Passarelli Mantovani, Silvia Accordini, Francesca Alladio, Federico Gobbi","doi":"10.3201/eid3012.241470","DOIUrl":"https://doi.org/10.3201/eid3012.241470","url":null,"abstract":"<p>A febrile man in Italy who had traveled to Cuba in July 2024 was diagnosed with Oropouche fever. Reverse transcription PCR detected prolonged shedding of Oropouche virus RNA in whole blood, serum, urine, and semen. Sixteen days after symptom onset, replication-competent virus was detected in semen, suggesting risk for sexual transmission.</p>","PeriodicalId":11595,"journal":{"name":"Emerging Infectious Diseases","volume":null,"pages":null},"PeriodicalIF":11.8,"publicationDate":"2024-10-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142384158","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信